United States Biotechnology & Medical Research

Dyne Therapeutics Inc (DYN)

Track

Dyne Therapeutics experienced significant insider trading activity recently, characterized by substantial divestments from major shareholders and corporate officers. Over the past ninety days, seventy-seven transactions occurred, primarily sales. This selling trend follows a period where the stock price appreciated by fifty percent, despite a negative earnings report.

Active selling signal · Moderate

Top insider sells (60d)

Top cluster sells (60d)

Featured in screeners

Active selling signal · Moderate

Top insider sells

Top cluster sells

Ticker: DYN Exchange: NSM

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

10 activity signals detected for Dyne Therapeutics Inc

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Dyne Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Proposed sale 13 Aug 2026

Value US$4,745,935.06 | Price 88.72 | Shares 45,425

Proposed sale 13 Aug 2026

Value US$1,849,760.33 | Price 132.85 | Shares 87,068

Proposed sale 13 Aug 2026

Value US$100,000.00 | Price 26.17 | Shares 1,000

Proposed sale 13 Aug 2026

Value US$100,000.00 | Price 26.28 | Shares 1,000

Proposed sale 13 Aug 2026

Value US$100,000.00 | Price 26.28 | Shares 1,000

Proposed sale 13 Aug 2026

Value US$100,000.00 | Price 26.28 | Shares 1,000

Planned sale 27 Jul 2026

Value US$100,000.00 | Price 26.04 | Shares 1,000 (-0.1%)

Planned sale 27 Jul 2026

Value US$100,000.00 | Price 25.50 | Shares 1,000 (-6.7%)

Proposed sale 27 Jul 2026

Value US$100,000.00 | Price 25.51 | Shares 1,000

Sale 7 Jul 2026

Value US$118,050.00 | Price 23.61 | Shares 5,000 (-62.8%)

Planned sale 7 Jul 2026

Value US$275,527.30 | Price 23.62 | Shares 11,665 (-1.4%)

Planned sale 7 Jul 2026

Value US$1,139,801.81 | Price 23.17 | Shares 49,193 (-5.6%)

Planned sale 7 Jul 2026

Value US$350,615.28 | Price 23.62 | Shares 14,844 (-1.3%)

Planned sale 7 Jul 2026

Value US$1,449,121.31 | Price 23.17 | Shares 62,543 (-5.1%)

Planned sale 7 Jul 2026

Value US$698,844.94 | Price 23.62 | Shares 29,587 (-0.7%)

Planned sale 7 Jul 2026

Value US$2,881,861.43 | Price 23.17 | Shares 124,379 (-2.9%)

Proposed sale 7 Jul 2026

Value US$114,200.00 | Price 22.84 | Shares 5,000

Proposed sale 7 Jul 2026

Value US$114,200.00 | Price 22.84 | Shares 5,000

Proposed sale 7 Jul 2026

Value US$3,516,583.44 | Price 22.84 | Shares 153,966

Proposed sale 7 Jul 2026

Value US$3,516,583.44 | Price 22.84 | Shares 153,966

Proposed sale 7 Jul 2026

Value US$1,767,519.08 | Price 22.84 | Shares 77,387

Proposed sale 7 Jul 2026

Value US$1,767,519.08 | Price 22.84 | Shares 77,387

Proposed sale 7 Jul 2026

Value US$1,389,996.72 | Price 22.84 | Shares 60,858

Proposed sale 7 Jul 2026

Value US$1,389,996.72 | Price 22.84 | Shares 60,858

Planned sale 6 Jul 2026

Value US$2,279,433.01 | Price 22.79 | Shares 100,019 (-10.2%)

Planned sale 6 Jul 2026

Value US$2,898,477.78 | Price 22.79 | Shares 127,182 (-9.5%)

Planned sale 6 Jul 2026

Value US$5,766,758.81 | Price 22.79 | Shares 253,039 (-5.7%)

Proposed sale 6 Jul 2026

Value US$5,837,609.73 | Price 23.07 | Shares 253,039

Proposed sale 6 Jul 2026

Value US$2,307,438.33 | Price 23.07 | Shares 100,019

Proposed sale 6 Jul 2026

Value US$2,934,088.74 | Price 23.07 | Shares 127,182

Planned sale 29 Jun 2026

Value US$860,440.28 | Price 21.14 | Shares 40,702 (-4.0%)

Planned sale 29 Jun 2026

Value US$1,094,121.84 | Price 21.14 | Shares 51,756 (-3.7%)

Planned sale 29 Jun 2026

Value US$2,176,764.66 | Price 21.14 | Shares 102,969 (-2.2%)

Proposed sale 29 Jun 2026

Value US$1,083,770.64 | Price 20.94 | Shares 51,756

Proposed sale 29 Jun 2026

Value US$2,156,170.86 | Price 20.94 | Shares 102,969

Proposed sale 29 Jun 2026

Value US$852,299.88 | Price 20.94 | Shares 40,702

Planned sale 26 Jun 2026

Value US$1,370,666.08 | Price 21.28 | Shares 64,411 (-6.0%)

Planned sale 26 Jun 2026

Value US$1,742,895.84 | Price 21.28 | Shares 81,903 (-5.5%)

Planned sale 26 Jun 2026

Value US$3,467,661.12 | Price 21.28 | Shares 162,954 (-3.4%)

Proposed sale 26 Jun 2026

Value US$1,688,020.83 | Price 20.61 | Shares 81,903

Proposed sale 26 Jun 2026

Value US$3,358,481.94 | Price 20.61 | Shares 162,954

Proposed sale 26 Jun 2026

Value US$1,327,510.71 | Price 20.61 | Shares 64,411

Sale 25 Jun 2026

Value US$48,113.94 | Price 20.37 | Shares 2,362 (-1.9%)

Proposed sale 25 Jun 2026

Value US$48,103.00 | Price 20.37 | Shares 2,362

Planned sale 25 Jun 2026

Value US$105,900.90 | Price 21.10 | Shares 5,019 (-0.5%)

Planned sale 25 Jun 2026

Value US$134,660.20 | Price 21.10 | Shares 6,382 (-0.4%)

Planned sale 25 Jun 2026

Value US$267,948.90 | Price 21.10 | Shares 12,699 (-0.3%)

Proposed sale 25 Jun 2026

Value US$129,746.06 | Price 20.33 | Shares 6,382

Proposed sale 25 Jun 2026

Value US$102,036.27 | Price 20.33 | Shares 5,019

Proposed sale 25 Jun 2026

Value US$258,170.67 | Price 20.33 | Shares 12,699

Planned sale 24 Jun 2026

Value US$419,832.46 | Price 21.02 | Shares 19,973 (-1.8%)

Planned sale 24 Jun 2026

Value US$533,844.94 | Price 21.02 | Shares 25,397 (-1.7%)

Planned sale 24 Jun 2026

Value US$1,062,140.60 | Price 21.02 | Shares 50,530 (-1.1%)

Proposed sale 24 Jun 2026

Value US$514,543.22 | Price 20.26 | Shares 25,397

Proposed sale 24 Jun 2026

Value US$404,652.98 | Price 20.26 | Shares 19,973

Proposed sale 24 Jun 2026

Value US$1,023,737.80 | Price 20.26 | Shares 50,530

Planned sale 23 Jun 2026

Value US$650,254.62 | Price 21.13 | Shares 30,774 (-2.7%)

Planned sale 23 Jun 2026

Value US$826,838.03 | Price 21.13 | Shares 39,131 (-2.5%)

Planned sale 23 Jun 2026

Value US$1,645,076.15 | Price 21.13 | Shares 77,855 (-1.6%)

Planned sale 23 Jun 2026

Value US$35,582.75 | Price 21.47 | Shares 1,657 (-0.0%)

Planned sale 23 Jun 2026

Value US$1,506,766.16 | Price 21.04 | Shares 71,629 (-1.8%)

Proposed sale 23 Jun 2026

Value US$642,253.38 | Price 20.87 | Shares 30,774

Proposed sale 23 Jun 2026

Value US$816,663.97 | Price 20.87 | Shares 39,131

Planned sale 22 Jun 2026

Value US$3,922,262.52 | Price 20.57 | Shares 190,676 (-4.6%)

Proposed sale 22 Jun 2026

Value US$1,624,833.85 | Price 20.87 | Shares 77,855

Planned sale 18 Jun 2026

Value US$941,373.42 | Price 20.07 | Shares 46,901 (-1.1%)

Planned sale 17 Jun 2026

Value US$754,316.07 | Price 20.14 | Shares 37,454 (-0.9%)

Proposed sale 17 Jun 2026

Value US$6,384,650.61 | Price 18.33 | Shares 348,317

Planned sale 16 Jun 2026

Value US$16,258.71 | Price 18.33 | Shares 887 (-0.5%)

Planned sale 16 Jun 2026

Value US$49,179.39 | Price 18.33 | Shares 2,683 (-0.7%)

Proposed sale 16 Jun 2026

Value US$49,191.00 | Price 18.33 | Shares 2,683

Planned sale 16 Jun 2026

Value US$2,657.85 | Price 18.33 | Shares 145 (-0.1%)

Buy 8 Jun 2026

Value US$33,880.00 | Price 16.94 | Shares 2,000 (+8.9%)

Buy 3 Jun 2026

Value US$43,700.00 | Price 17.48 | Shares 2,500 (+12.5%)

Buy 3 Jun 2026

Value US$43,700.00 | Price 17.48 | Shares 2,500 (+12.5%)

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-08-13	2026-08-13	PrS Proposed sale	2.0 Atlas Venture Fund XI, LP Shareholder	45,425 88.72 US$4,745,935	45,425	88.72	US$4,745,935
2026-08-13	2026-08-13	PrS Proposed sale	3.4 Atlas Venture Opportunity Fund II, LP Shareholder	87,068 132.85 US$1,849,760	87,068	132.85	US$1,849,760
2026-08-13	2026-08-13	PrS Proposed sale	Atlas Venture Opportunity Fund I, LP Shareholder	50,029 319.36 US$2,966,376	50,029	319.36	US$2,966,376
2026-08-13	2026-08-13	PrS Proposed sale	2.1 Cox John Officer Officer	1,000 26.28 US$100,000	1,000	26.28	US$100,000
2026-08-13	2026-08-13	PrS Proposed sale	Kerr Douglas Officer Officer	1,000 26.28 US$100,000	1,000	26.28	US$100,000
2026-08-13	2026-08-13	PrS Proposed sale	3.6 Lucera Erick Officer Officer	1,000 26.28 US$100,000	1,000	26.28	US$100,000
2026-07-29	2026-07-27	PlS Planned sale	3.9 Kersten Dirk Non-Executive Director	1,000 -0.1% 26.04 US$100,000	1,000 -0.1%	26.04	US$100,000
2026-07-29	2026-07-27	PlS Planned sale	3.9 Kersten Dirk Non-Executive Director	1,000 -6.7% 25.50 US$100,000	1,000 -6.7%	25.50	US$100,000
2026-07-27	2026-07-27	PrS Proposed sale	ForDyne B.V. Affiliate	1,000 25.51 US$100,000	1,000	25.51	US$100,000
2026-07-08	2026-07-07	S Sale	3.5 Rhodes Jason P Non-Executive Director	5,000 -62.8% 23.61 US$118,050	5,000 -62.8%	23.61	US$118,050
2026-07-08	2026-07-07	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	11,665 -1.4% 23.62 US$275,527	11,665 -1.4%	23.62	US$275,527
2026-07-08	2026-07-07	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	49,193 -5.6% 23.17 US$1,139,802	49,193 -5.6%	23.17	US$1,139,802
2026-07-08	2026-07-07	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	14,844 -1.3% 23.62 US$350,615	14,844 -1.3%	23.62	US$350,615
2026-07-08	2026-07-07	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	62,543 -5.1% 23.17 US$1,449,121	62,543 -5.1%	23.17	US$1,449,121
2026-07-08	2026-07-07	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	29,587 -0.7% 23.62 US$698,845	29,587 -0.7%	23.62	US$698,845
2026-07-08	2026-07-07	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	124,379 -2.9% 23.17 US$2,881,861	124,379 -2.9%	23.17	US$2,881,861
2026-07-07	2026-07-07	PrS Proposed sale	ATLAS VENTURE ASSOCIATES XI, L.P. Shareholder	5,000 22.84 US$114,200	5,000	22.84	US$114,200
2026-07-07	2026-07-07	PrS Proposed sale	ATLAS VENTURE ASSOCIATES XI, L.P. Shareholder	5,000 22.84 US$114,200	5,000	22.84	US$114,200
2026-07-07	2026-07-07	PrS Proposed sale	2.0 Atlas Venture Fund XI, LP Shareholder	153,966 22.84 US$3,516,583	153,966	22.84	US$3,516,583
2026-07-07	2026-07-07	PrS Proposed sale	2.0 Atlas Venture Fund XI, LP Shareholder	153,966 22.84 US$3,516,583	153,966	22.84	US$3,516,583
2026-07-07	2026-07-07	PrS Proposed sale	3.4 Atlas Venture Opportunity Fund II, LP Shareholder	77,387 22.84 US$1,767,519	77,387	22.84	US$1,767,519
2026-07-07	2026-07-07	PrS Proposed sale	3.4 Atlas Venture Opportunity Fund II, LP Shareholder	77,387 22.84 US$1,767,519	77,387	22.84	US$1,767,519
2026-07-07	2026-07-07	PrS Proposed sale	Atlas Venture Opportunity Fund I, LP Shareholder	60,858 22.84 US$1,389,997	60,858	22.84	US$1,389,997
2026-07-07	2026-07-07	PrS Proposed sale	Atlas Venture Opportunity Fund I, LP Shareholder	60,858 22.84 US$1,389,997	60,858	22.84	US$1,389,997
2026-07-08	2026-07-06	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	100,019 -10.2% 22.79 US$2,279,433	100,019 -10.2%	22.79	US$2,279,433
2026-07-08	2026-07-06	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	127,182 -9.5% 22.79 US$2,898,478	127,182 -9.5%	22.79	US$2,898,478
2026-07-08	2026-07-06	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	253,039 -5.7% 22.79 US$5,766,759	253,039 -5.7%	22.79	US$5,766,759
2026-07-06	2026-07-06	PrS Proposed sale	2.0 Atlas Venture Fund XI, LP Shareholder	253,039 23.07 US$5,837,610	253,039	23.07	US$5,837,610
2026-07-06	2026-07-06	PrS Proposed sale	Atlas Venture Opportunity Fund I, LP Shareholder	100,019 23.07 US$2,307,438	100,019	23.07	US$2,307,438
2026-07-06	2026-07-06	PrS Proposed sale	3.4 Atlas Venture Opportunity Fund II, LP Shareholder	127,182 23.07 US$2,934,089	127,182	23.07	US$2,934,089
2026-06-30	2026-06-29	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	40,702 -4.0% 21.14 US$860,440	40,702 -4.0%	21.14	US$860,440
2026-06-30	2026-06-29	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	51,756 -3.7% 21.14 US$1,094,122	51,756 -3.7%	21.14	US$1,094,122
2026-06-30	2026-06-29	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	102,969 -2.2% 21.14 US$2,176,765	102,969 -2.2%	21.14	US$2,176,765
2026-06-29	2026-06-29	PrS Proposed sale	3.4 Atlas Venture Opportunity Fund II, LP Shareholder	51,756 20.94 US$1,083,771	51,756	20.94	US$1,083,771
2026-06-29	2026-06-29	PrS Proposed sale	2.0 Atlas Venture Fund XI, LP Shareholder	102,969 20.94 US$2,156,171	102,969	20.94	US$2,156,171
2026-06-29	2026-06-29	PrS Proposed sale	Atlas Venture Opportunity Fund I, LP Shareholder	40,702 20.94 US$852,300	40,702	20.94	US$852,300
2026-06-30	2026-06-26	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	64,411 -6.0% 21.28 US$1,370,666	64,411 -6.0%	21.28	US$1,370,666
2026-06-30	2026-06-26	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	81,903 -5.5% 21.28 US$1,742,896	81,903 -5.5%	21.28	US$1,742,896
2026-06-30	2026-06-26	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	162,954 -3.4% 21.28 US$3,467,661	162,954 -3.4%	21.28	US$3,467,661
2026-06-26	2026-06-26	PrS Proposed sale	3.4 Atlas Venture Opportunity Fund II, LP Shareholder	81,903 20.61 US$1,688,021	81,903	20.61	US$1,688,021
2026-06-26	2026-06-26	PrS Proposed sale	2.0 Atlas Venture Fund XI, LP Shareholder	162,954 20.61 US$3,358,482	162,954	20.61	US$3,358,482
2026-06-26	2026-06-26	PrS Proposed sale	Atlas Venture Opportunity Fund I, LP Shareholder	64,411 20.61 US$1,327,511	64,411	20.61	US$1,327,511
2026-06-26	2026-06-25	S Sale	3.6 Lucera Erick Chief Financial Officer Officer	2,362 -1.9% 20.37 US$48,114	2,362 -1.9%	20.37	US$48,114
2026-06-26	2026-06-25	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	5,019 -0.5% 21.10 US$105,901	5,019 -0.5%	21.10	US$105,901
2026-06-26	2026-06-25	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	6,382 -0.4% 21.10 US$134,660	6,382 -0.4%	21.10	US$134,660
2026-06-26	2026-06-25	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	12,699 -0.3% 21.10 US$267,949	12,699 -0.3%	21.10	US$267,949
2026-06-25	2026-06-25	PrS Proposed sale	3.4 Atlas Venture Opportunity Fund II, LP Shareholder	6,382 20.33 US$129,746	6,382	20.33	US$129,746
2026-06-25	2026-06-25	PrS Proposed sale	Atlas Venture Opportunity Fund I, LP Shareholder	5,019 20.33 US$102,036	5,019	20.33	US$102,036
2026-06-25	2026-06-25	PrS Proposed sale	2.0 Atlas Venture Fund XI, LP Shareholder	12,699 20.33 US$258,171	12,699	20.33	US$258,171
2026-06-25	2026-06-25	PrS Proposed sale	3.6 Lucera Erick Officer Officer	2,362 20.37 US$48,103	2,362	20.37	US$48,103
2026-06-26	2026-06-24	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	19,973 -1.8% 21.02 US$419,832	19,973 -1.8%	21.02	US$419,832
2026-06-26	2026-06-24	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	25,397 -1.7% 21.02 US$533,845	25,397 -1.7%	21.02	US$533,845
2026-06-26	2026-06-24	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	50,530 -1.1% 21.02 US$1,062,141	50,530 -1.1%	21.02	US$1,062,141
2026-06-24	2026-06-24	PrS Proposed sale	3.4 Atlas Venture Opportunity Fund II, LP Shareholder	25,397 20.26 US$514,543	25,397	20.26	US$514,543
2026-06-24	2026-06-24	PrS Proposed sale	Atlas Venture Opportunity Fund I, LP Shareholder	19,973 20.26 US$404,653	19,973	20.26	US$404,653
2026-06-24	2026-06-24	PrS Proposed sale	2.0 Atlas Venture Fund XI, LP Shareholder	50,530 20.26 US$1,023,738	50,530	20.26	US$1,023,738
2026-06-26	2026-06-23	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	30,774 -2.7% 21.13 US$650,255	30,774 -2.7%	21.13	US$650,255
2026-06-26	2026-06-23	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	39,131 -2.5% 21.13 US$826,838	39,131 -2.5%	21.13	US$826,838
2026-06-26	2026-06-23	PlS Planned sale	3.5 Rhodes Jason P Non-Executive Director	77,855 -1.6% 21.13 US$1,645,076	77,855 -1.6%	21.13	US$1,645,076
2026-06-24	2026-06-23	PlS Planned sale	3.9 Kersten Dirk Non-Executive Director	1,657 -0.0% 21.47 US$35,583	1,657 -0.0%	21.47	US$35,583
2026-06-24	2026-06-23	PlS Planned sale	3.9 Kersten Dirk Non-Executive Director	71,629 -1.8% 21.04 US$1,506,766	71,629 -1.8%	21.04	US$1,506,766
2026-06-23	2026-06-23	PrS Proposed sale	Atlas Venture Opportunity Fund I, LP Shareholder	30,774 20.87 US$642,253	30,774	20.87	US$642,253
2026-06-23	2026-06-23	PrS Proposed sale	3.4 Atlas Venture Opportunity Fund II, LP Shareholder	39,131 20.87 US$816,664	39,131	20.87	US$816,664
2026-06-24	2026-06-22	PlS Planned sale	3.9 Kersten Dirk Non-Executive Director	190,676 -4.6% 20.57 US$3,922,263	190,676 -4.6%	20.57	US$3,922,263
2026-06-23	2026-06-22	PrS Proposed sale	2.0 Atlas Venture Fund XI, LP Shareholder	77,855 20.87 US$1,624,834	77,855	20.87	US$1,624,834
2026-06-22	2026-06-18	PlS Planned sale	3.9 Kersten Dirk Non-Executive Director	46,901 -1.1% 20.07 US$941,373	46,901 -1.1%	20.07	US$941,373
2026-06-22	2026-06-17	PlS Planned sale	3.9 Kersten Dirk Non-Executive Director	37,454 -0.9% 20.14 US$754,316	37,454 -0.9%	20.14	US$754,316
2026-06-17	2026-06-17	PrS Proposed sale	ForDyne B.V. Affiliate	348,317 18.33 US$6,384,651	348,317	18.33	US$6,384,651
2026-06-17	2026-06-16	PlS Planned sale	Kerr Douglas Chief Medical Officer Officer	887 -0.5% 18.33 US$16,259	887 -0.5%	18.33	US$16,259
2026-06-17	2026-06-16	PlS Planned sale	2.1 Cox John CEO & President Executive Director	2,683 -0.7% 18.33 US$49,179	2,683 -0.7%	18.33	US$49,179
2026-06-17	2026-06-16	PlS Planned sale	0.9 Friedl-Naderer Johanna Chief Commercial Officer Officer	145 -0.1% 18.33 US$2,658	145 -0.1%	18.33	US$2,658
2026-06-16	2026-06-16	PrS Proposed sale	2.1 Cox John Officer Officer	2,683 18.33 US$49,191	2,683	18.33	US$49,191
2026-06-09	2026-06-08	B Purchase	3.8 Posner Brian S Non-Executive Director	2,000 +8.9% 16.94 US$33,880	2,000 +8.9%	16.94	US$33,880
2026-06-05	2026-06-03	B Purchase	3.8 Posner Brian S Non-Executive Director	2,500 +12.5% 17.48 US$43,700	2,500 +12.5%	17.48	US$43,700
2026-06-05	2026-06-03	B Purchase	3.8 Posner Brian S Non-Executive Director	2,500 +12.5% 17.48 US$43,700	2,500 +12.5%	17.48	US$43,700

Explore more

More insider trading research around Dyne Therapeutics Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in North America

Dyne Therapeutics Inc (DYN)

Track

Featured in screeners

Upgrade for signal details

Transactions

Insider

Sort by

Trades

Explore more